Please use this identifier to cite or link to this item:
https://dspace.uzhnu.edu.ua/jspui/handle/lib/37541
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sirchak, Yelyzaveta | - |
dc.contributor.author | Patskun, Silviya | - |
dc.contributor.author | Bedey, Nelli | - |
dc.date.accessioned | 2021-11-10T17:32:41Z | - |
dc.date.available | 2021-11-10T17:32:41Z | - |
dc.date.issued | 2020-11 | - |
dc.identifier.uri | https://dspace.uzhnu.edu.ua/jspui/handle/lib/37541 | - |
dc.description.abstract | The aim: To study the gastrin level dynamics in patients with diabetes mellitus (DM) 2 type and chronic gastritis (CG) on the background of antihelicobacter therapy (AHT). Materials and methods: 60 patients with DM type 2 and HP-associated CG underwent examination. Patients were divided into two groups of 30 patients each: group 1 included patients who received only standard AHT, group 2 – patients who in addition to standard AHT received the drug SB (Normagut, company Mega) 2 capsules 2 times/day. Results: According to our study results yeast SB, not only increase the HP eradication rate but together with the standard AHT contribute to the serum gastrin reduction, which is a gastric acid stimulator, which in turn leads to an improvement in the CG clinical course. Conclusions: Patients with DM type 2 and CG associated with HP should include yeast SB to standard AHT as they reduce side effects from this treatment (by an average of 20%), increase the eradication frequency (by 10%), and also lead to significant decrease in serum gastrin (up to 82.15 ± 2.47 pg/ml).A decrease in serum gastrin levels in patients with HP-associated CG and DM type 2 leads to an improvement in the clinical course of the diseases, namely a decrease in nausea, diarrhea, abdominal pain, and discomfort incidence. | uk |
dc.language.iso | en | uk |
dc.publisher | Wiadomości Lekarskie | uk |
dc.relation.ispartofseries | VOLUME LXXIII, ISSUE 11; | - |
dc.subject | diabetes mellitus 2 type | uk |
dc.subject | chronic gastritis | uk |
dc.subject | helicobacter pylori | uk |
dc.subject | saccharomyces boulardii | uk |
dc.title | DYNAMICS OF GASTRIN LEVEL IN PATIENTS WITH DIABETES MELLITUS 2 TYPE AND CHRONIC GASTRITIS AFTER HELICOBACTER PYLORI ERADICATION THERAPY | uk |
dc.type | Text | uk |
dc.pubType | Стаття | uk |
Appears in Collections: | Наукові публікації кафедри фізіології та патофізіології |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.